Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GH/IGF-1 axis in children with ataxia telangiectasia
2009-015739-34Phase 4Completed
- Sponsor
- Goethe University Frankfurt
- Start
- Sep 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of somatotropin in ataxia-telangiectasia (AT), growth hormone deficiency (GHD) and growth disorder, sponsored by Goethe University Frankfurt. Primary endpoint: IGF-1/GH increase after arginine provocation test. Started Sep 2009; status: completed.
02
Drugs
somatotropin
03
Conditions
ataxia-telangiectasia (AT)growth hormone deficiency (GHD)growth disorder
Beyond the preview
Go deeper on 2009-015739-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015739-34.